» Articles » PMID: 21257717

What Do Prostate Cancer Patients Die Of?

Overview
Journal Oncologist
Specialty Oncology
Date 2011 Jan 25
PMID 21257717
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A recent rise in the incidence of prostate cancer and a more favorable outcome have increased the proportions of other causes of death in affected men. Extending the survival of prostate cancer patients thus requires knowledge of all causes of death.

Methods: Data on the population, cancers, and causes of death were gathered from the nationwide Swedish Family-Cancer Database. A Cox regression model, comparing prostate cancer patients with all other men, was applied. Hazard ratios (HR) were calculated both for the underlying cause and for dying with a specific cause listed among multiple causes of death.

Findings: Among 686,500 observed deaths, 62,500 were prostate cancer patients. For underlying causes other than prostate cancer, the highest cause-specific HRs were found for external causes (HR, 1.24; 95% confidence interval [CI], 1.16-1.31), diseases of the pulmonary circulation (HR, 1.22; 95% CI, 1.09-1.37), and heart failure (HR, 1.18; 95% CI, 1.11-1.24). For specific multiple causes, the highest HRs were found for anemia (HR, 2.28; 95% CI, 2.14-2.42), diseases of the pulmonary circulation (HR, 1.61; 95% CI, 1.55-1.68), and urinary system disease (HR, 1.90; 95% CI, 1.84-1.96).

Interpretations: Prostate cancer patients have a higher risk for dying from various causes other than prostate cancer, including external causes and heart failure. Mechanisms have been proposed linking these elevated risks to both cancer and treatment. More attention should be paid to comorbidities in men with prostate cancer. The present study fulfills a gap in the knowledge of death causes in prostate cancer patients.

Citing Articles

Couple-based lifestyle intervention for minority prostate cancer survivors: a randomized feasibility trial.

Cho D, Li Y, Basen-Engquist K, Acquati C, Nguyen N, Ma H Ann Behav Med. 2025; 59(1).

PMID: 39945428 PMC: 11822470. DOI: 10.1093/abm/kaaf010.


'Just because I have prostate cancer doesn't mean that I can't do things' - men's experiences of the acceptability of an exercise intervention for prostate cancer during treatment.

Murphy K, Kehoe B, Denieffe S, McGrath A, Hacking D, Fairman C BMC Cancer. 2024; 24(1):949.

PMID: 39095735 PMC: 11297682. DOI: 10.1186/s12885-024-12687-8.


Effects of high-intensity interval training on cardiometabolic biomarkers in patients with prostate cancer undergoing active surveillance: a randomized controlled trial.

Kang D, Field C, Patel D, Fairey A, Boule N, Dieli-Conwright C Prostate Cancer Prostatic Dis. 2024; .

PMID: 39009705 DOI: 10.1038/s41391-024-00867-3.


Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physicians.

Nguyen D, Mousa A, Klotz L, Niazi T, Pouliot F, Kokorovic A Can Urol Assoc J. 2024; 18(6):212-215.

PMID: 38587979 PMC: 11230694. DOI: 10.5489/cuaj.8687.


Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.

Hemminki K, Zitricky F, Sundquist K, Sundquist J, Forsti A, Hemminki A Cancer Med. 2024; 13(7):e7126.

PMID: 38545829 PMC: 10974700. DOI: 10.1002/cam4.7126.


References
1.
Saylor P, Keating N, Smith M . Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy. J Gen Intern Med. 2009; 24 Suppl 2:S389-94. PMC: 2763167. DOI: 10.1007/s11606-009-0968-y. View

2.
Varki A . Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood. 2007; 110(6):1723-9. PMC: 1976377. DOI: 10.1182/blood-2006-10-053736. View

3.
Hemminki K, Ji J, Brandt A, Mousavi S, Sundquist J . The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2009; 126(10):2259-67. DOI: 10.1002/ijc.24795. View

4.
Fall K, Fang F, Mucci L, Ye W, Andren O, Johansson J . Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med. 2009; 6(12):e1000197. PMC: 2784954. DOI: 10.1371/journal.pmed.1000197. View

5.
Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A . Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006; 166(13):1380-8. PMC: 2645631. DOI: 10.1001/archinte.166.13.1380. View